Get started
SPDR Select Sector Fund - Health CareSPDR Select Sector Fund - Health CareSPDR Select Sector Fund - Health Care

SPDR Select Sector Fund - Health Care

No trades
See on Supercharts
Overview Analysis Holdings News
Ideas
Discussions Technicals Seasonals Options

XLV trade ideas

Healthcare Is Leading the Market This YearBelieve it or not, healthcare is the top performing sector so far in 2025. (It’s up about 9 percent, according to TradeStation data. That puts it fractionally ahead of financials.) Today’s chart of the SPDR Select Sector Health Care ETF highlights some potentially interesting patterns. First is the rally from January 3 (first Friday of the year) through February 5. XLV pulled back to retrace almost exactly half the advance, which may suggest direction is pointing upward. It has also been fighting potential resistance at its 200-day simple moving average (SMA), but closed above it on Friday. Speaking of Friday, the fund initially fell below Thursday’s low. It then bounced and cleared the previous session’s high. Is that bullish outside candle a sign of animal spirits? XLV also had its highest weekly close since early November. Finally, the 8-day exponential moving average (EMA) has stayed above the 21-day EMA. Such price action may be consistent with a short-term uptrend. Standardized Performances for the ETF mentioned above: SPDR Select Sector Health Care ETF (XLV) 1-year: +4.62% 5-years: +48.15% 10-year: +114.50% (As of January 31, 2025) Exchange Traded Funds ("ETFs") are subject to management fees and other expenses. Before making investment decisions, investors should carefully read information found in the prospectus or summary prospectus, if available, including investment objectives, risks, charges, and expenses. Click here to find the prospectus. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options and futures. If you're born to trade, we could be for you. See our Overview for more. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options or futures); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at www.TradeStation.com . Before trading any asset class, customers must read the relevant risk disclosure statements on www.TradeStation.com . System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors. Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission and a futures commission merchant licensed with the Commodity Futures Trading Commission). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association, and a number of exchanges. TradeStation Securities, Inc. and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., both operating, and providing products and services, under the TradeStation brand and trademark. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit www.TradeStation.com for further important information explaining what this means.
AMEX:XLV
by TradeStation
Park your Funds in HealthCare! The 2024 performance of health care stocks lagged behind due to investor preference for higher-growth technology sectors. This underperformance has created more favorable valuations, setting the stage for a potentially stronger outlook in 2025. Key drivers for the health care sector include: 1. Innovation Advances in biotechnology are producing cutting-edge treatments, particularly in specialty drugs. Leading companies, such as Alnylam Pharmaceuticals and argenx SE, are developing innovative therapies for rare diseases and autoimmune disorders. Specialty drugs, which account for over half of pharmaceutical sales, are experiencing significant growth. 2. Policy Environment A possible shift in the U.S. administration could reduce regulatory uncertainty. Managed-care providers may benefit from Medicare Advantage policy adjustments, fostering a more stable operating environment. 3. Attractive Valuations After 2024's underperformance, the sector offers lower valuation entry points. Long-term demographic trends, such as the aging population in the U.S., are expected to sustain growth and demand in health care services and innovations. Conclusion: While near-term challenges persist, the combination of groundbreaking innovations, potential policy shifts, and compelling valuations positions the health care sector as an attractive opportunity for investors in 2025 and beyond.
AMEX:XLVLong
by Audacity618
Healthcare Sector (XLV) Long-Term BuyI believe healthcare will be the next rotation coming out of this tech bull run. Using the Trade Jeanie (Jeanius Screener/Indicator), I was able to see the current technical buy signals happening on AMEX:XLV : Took out an untested low Price touching 21EMA while the 9EMA > 21EMA Retested a level that was broken to create a break of structure (BOS & Retest) The Jeanius Indicator shows green 'Combo' labels every time this same combination of signals happened
AMEX:XLVLong
by jeanius_tech
2
Healthcare Sector Poised For A 7% to 15% Rally Into Early 2025My continued research to help traders shows the US Healthcare and Biotech sectors are poised for a very large rally phase into early 2025. Particularly, XLV and XBI seem uniquely setup to rally more than 9-10% over the next 60 to 90+ days. This video explains how I use my Adaptive Dynamic Learning Predictive Modeling system to find opportunities other people miss. Using technology, predictive modeling, and inference engines like this is one advantage I have because I can build any type of technology or system I like - and use it on any symbol or interval I like. Now is the time to prepare for the big moves headed into 2025. Follow my research if you want to target the biggest price swings in the markets. Get some. #trading #research #investing #tradingalgos #tradingsignals #cycles #fibonacci #elliotwave #modelingsystems #stocks #bitcoin #btcusd #cryptos #spy #es #nq #gold
AMEX:XLVLong
by BradMatheny
Health Care ETF May Have Broken OutMany observers have spoken recently about market rotation. They often cite money shifting from megacaps to small caps. But another forgotten sector could be benefiting as well: healthcare. The first pattern on today’s chart of the SPDR Select Sector Health Care ETF is the June 24 close of $147.09. XLV was trapped below this approximate level since late February, but crossed above it earlier in July. Prices are bouncing after retesting it last week. Has old resistance become new support? Second, you have a series of higher weekly lows since mid-April. Those may reflect accumulation by long-term investors. Third, prices are near the 50- and 100-day simple moving averages (SMAs). Both SMAs are also near each other, which may create potential for price expansion. Finally, MACD recently tuned positive. Standardized Performances for the ETF mentioned above: SPDR Select Sector Health Care ETF (XLV) 1-year: +9.81% 5-years: +58.70% 10-year: +142.80% (As of June 28, 2024) Performance data shown reflects past performance and is no guarantee of future performance. The information provided is not meant to predict or project the performance of a specific investment or investment strategy and current performance may be lower or higher than the performance data shown. Accordingly, this information should not be relied upon when making an investment decision. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options and futures. See our Overview for more. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options or futures); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at www.TradeStation.com . Before trading any asset class, customers must read the relevant risk disclosure statements on www.TradeStation.com . System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors. Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission and a futures commission merchant licensed with the Commodity Futures Trading Commission). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association, and a number of exchanges. TradeStation Securities, Inc. and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., both operating, and providing products and services, under the TradeStation brand and trademark. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit www.TradeStation.com for further important information explaining what this means. Exchange Traded Funds ("ETFs") are subject to management fees and other expenses. Before making investment decisions, investors should carefully read information found in the prospectus or summary prospectus, if available, including investment objectives, risks, charges, and expenses. Click here to find the prospectus.
AMEX:XLV
by TradeStation
XLV is shaping falling wedgeBullish context: weekly uptrend Price position: near last weekly trend low Pattern: four consecutive red days with little upthrust (progression of lows) It looks like previous weekly consolidation area is providing support, and bears are too exhausted to break through it now. This provides an opportunity for a long play. An example of possible trade is shown on the chart. It is important that today closes above 138.6, otherwise, setup is invalidated Disclaimer I don't give trading or investing advice, just sharing my thoughts.
AMEX:XLVLong
by hermes_trisme
XLV is in tight equilibrium; will break soonAMEX:XLV has formed a five-week equilibrium. The price contraction is already quite tight, indicating that this equilibrium could break very soon. The context is highly bullish: the XLV price is on a weekly uptrend, and the broader market is also showing strong performance. The odds are in favor of an upside breakout. On the chart, there is an example of a possible trade. Please note that while I’m not a fan of diagonal levels, I’ve drawn the triangle solely to illustrate the idea of equilibrium Disclaimer I don't give trading or investing advice, just sharing my thoughts.
AMEX:XLVLong
by hermes_trisme
The Healthcare Sector Index $XLV - Worth Watching SPDR Select Sector Fund – Healthcare Index AMEX:XLV The chart speaks for itself, we have our breakout levels and our break down levels. We enter on a breakout and set a stop 5% under that support and we exit and or short if we fall under the two underside support levels. Below I outline some reasons why the healthcare sector is worth paying attention too. The healthcare industry is worth $808 billion in the United States as of 2021. 65% of the industry’s revenue comes from patient care. The global healthcare industry is worth $12 trillion. In the U.S National health expenditures are projected to grow 5.4 percent, on average, over the course of 2023–31 and to account for roughly 20 percent of the economy by the end of that period. The insured share of the population is anticipated to exceed 92 percent through 2023 (figures pending), in part as a result of record-high Medicaid enrolment, and then decline toward 90 percent as coverage requirements related to the COVID-19 public health emergency expire. The growth of the health-care sector is evident in employment data as well. In 1990, about 8 million Americans worked in health care; that figure has since doubled to 16 million. That’s the largest single employment segment in our economy. In addition to the above, the west in general is an aging populace that is living longer. We will need these services more than we need staples during a recession. I believe this index can help us gauge the healthcare sector and what direction it will go next. We can watch the levels outlines and make a play if we wish. We have a hard upper boundary and lower boundary on a parallel channel on the chart. You know what to do when we breach any of these levels. Outlined on the chart XLV fund provides exposure to companies in pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology industries. XLV is the oldest in the segment, as such it is used widely for strategic or tactical positions. Since XLV is both cap weighted and fishes only from the S&P 500, it tilts heavily toward mega-caps. For focused exposure to leading health care names, XLV is tough to beat. Top Five Holdings UnitedHealth Group Inc NYSE:UNH 9.63% Eli Lilly and Co NYSE:LLY 9.19% Johnson & Johnson NYSE:JNJ 7.46% Merck & Co NYSE:MRK 5.46% AbbVie Inc 5.41% Stay Healthy and Nimble Folks PUKA
AMEX:XLV
by PukaCharts
XLV diamond top - remember XLU?AMEX:XLU has long been considered a safe sector for fixed income. Increasing cost of debt and regulatory restrictions on revenue with continued rising rates eventually pushed the largest growth opportunities in the sector out of favor and put downward pressure on the entire sector. Before the market came to appreciate this fundamental shift we can observe a diamond top formation. Diamond tops are bearish and a break below them experiences an average 20% decline. We can also take potential ranges from the measured height of the pattern and from 50% of the height of the pattern. We can see a diamond top formation with $XLV. I'm uncertain of what catalysts could pressure the healthcare sector at this time or when we would potentially see them. However, understanding the potential market reaction let's us prepare to protect positions or to capitalize on lows for long term opportunities.
AMEX:XLV
by Ben_1148x2
XLV still coiling, possible double top on the daily? On the weekly timeframe XLV continues to coil. On the daily timeframe we may have seen a double top after the rejection at the bottom of the gap (136.50 area). FWIW these options can move, but they are low volume. On high momentum days trading the same week can be effective. Personally, I prefer to bid for calls on red days and puts on green days with swing trade straddle targets in mind. I'm currently eyeing the gap above but a breakdown with a stronger market pullback is possible. I will be looking to add a long swing position after the Jackson Hole / JPow speech depending on market conditions.
AMEX:XLV
by DVM2Trader
XLV - Healthcare Sector Outlook Healthcare - XLV Health Care: Companies involved in healthcare-related services, including pharmaceuticals, biotechnology, medical devices, hospitals, and health insurance. Economic Cycle Sensitivity: Health care companies tend to be less sensitive to economic cycles. The demand for health care products and services remains relatively stable, driven by factors such as population demographics, technological advancements, and healthcare needs. However, during economic downturns, there may be some impact on discretionary healthcare spending. Top 20 Health Care Companies: Johnson & Johnson (JNJ) Pfizer Inc. (PFE) Merck & Co., Inc. (MRK) Novartis AG (NVS) AbbVie Inc. (ABBV) Amgen Inc. (AMGN) Bristol-Myers Squibb Company (BMY) Gilead Sciences, Inc. (GILD) Eli Lilly and Company (LLY) AstraZeneca PLC (AZN) GlaxoSmithKline plc (GSK) Medtronic plc (MDT) Abbott Laboratories (ABT) Sanofi (SNY) Novo Nordisk A/S (NVO) Boston Scientific Corporation (BSX) Thermo Fisher Scientific Inc. (TMO) Biogen Inc. (BIIB) Vertex Pharmaceuticals Incorporated (VRTX) Cardinal Health, Inc. (CAH) Technical Overview: The healthcare sector has been trading in larger range dating back to April 2021 between the prices of 118.75 - 143.42. On the Weekly and Monthly charts XLV has broken out of a large pennant with lots of volume. This could signal a big move in stocks heavily weighted in the healthcare sector. At the end of the week of July 17th, XLV closed above structure closing at 136.24. Although we still have one week left in this month, XLV has the potential to make a move up to the high of the monthly range to 143.42. This move could take a few months 2-3 or more. With the previous higher low on the weekly created by such a large candle, there could be a pull next week or two before continuing upward. Monitor tickers within this sector as the CLV makes it move. This chart should help provide some day trading and swing opportunities over the next few weeks or so. If swinging anything, watch for any major news or earnings along the way. Last thing, Although the healthcare sector isn't necessarily affected by the economic cycle, this big move/breakout could be an indicator of money rotating from tech, etc ...
AMEX:XLVLong
by Stockstradamus_